Patent details

LUC00208 Product Name: Combinaison de formotérol (y compris ses sels, esters, solvates ou énantiomères pharmaceutiquement acceptables), de glycopyrronium (y compris ses sels, esters, solvates ou énantiomères pharmaceutiquement acceptables) et de budésonide (y compris ses sels, esters, solvates ou énantiomères pharmaceutiquement acceptables)

Basic Information

Publication number:
LUC00208
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP107275513
Legal Status:
Inactive
Application number:
LUC00208
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1468
Marketing Authorization Type:
Marketing Authorization Date:
10/12/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
19/05/2021
First Marketing Authorization date:
10/12/2020
Grant date:
07/10/2022
Activation date:
Publication date:
19/05/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
28/05/2035
SPC Extension Expiration:
28/05/2035
Rejection date:
Withdrawal date:

Owner

From:
19/05/2021
 
 

Name:
Pearl Therapeutics Inc.
Address:
200 Saginaw Drive, Redwood City, CA 94063, United States (US)

Agent

Name:
ARONOVA S.A.
From:
19/05/2021
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/07
Publication date:
03/06/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2022/12
Publication date:
08/11/2022
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/05/2030
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
19/05/2021 Application Form 4
19/05/2021 Marketing authorization 3
19/05/2021 MA publication 3
19/05/2021 Marketing authorization 3
19/05/2021 Summary of the product caracteristics 46
19/05/2021 Outgoing Correspondence 1
10/10/2022 Outgoing Correspondence 1
19/05/2021 Publication 1
07/10/2022 Publication 1
07/10/2022 Certificate 1